Current Advances in LC-MSMS Methods to Determine Large Molecules of Drugs in Biological Samples
Read More
Will Brexit Have Any Impact on CROs?
The role of ADME in Phase 1 Clinical Trials
India – An attractive hub for clinical research
Current outlook of Biosimillar Development
How to Capture ICSRs for COVID Treatment
VEEDA CLINICAL RESEARCH awarded as Best Pharmaceutical CRO 2017 by APAC Indian Business Excellence Awards
Indian CRO industry is rich and diverse
There is further scope for developing the clinical research ecosystem, including regulatory pathways in India
VEEDA CRO celebrates 13 Years of success in serving the clients with best quality services
Website Launch
VASSOCHAM BEST CRO AWARD PR
Emerging Trends in Oncology Clinical Trials
Veeda Clinical Research Scores Another Perfect NPRA (Malaysian Regulatory Agency) Audit
Veeda Clinical Research Successfully Completed its 5th WHO Audit.
CX Partners Acquires Equity Stake in Veeda Clinical Research
Veeda Clinical Research Achieves ISO 27001:2013 Certification validating the Quality of its Information Security Management System
Veeda clinical research awarded as best quality clinical research organisation in India by World quality congress & awards 2019.
Veeda Clinical Research reaffirms Quality credentials with third successful NPRA (Malaysian Regulatory Agency) Inspection
Veeda Clinical Research reconfirms quality credentials with its seventh successful inspection by ANVISA (Brazilian Regulatory Agency)
Frost & Sullivan recognises Veeda Clinical Research as The Indian Clinical Research Organisation of the Year 2019.
Somru BioScience and Veeda Clinical Research Announce Joint Venture Global Biotherapeutic Contract Research Organization (CRO) in India
Somru BioScience and Veeda Clinical Research Announce Joint Venture, Global Biotherapeutic Contract Research Organization (CRO) in India
Veeda Clinical Research acquires stake in preclinical CRO, Bioneeds
CX partners backed Veeda Clinical raises $16 mn from Sabre partners, others
Veeda Clinical Research acquires a majority stake in Bioneeds
Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine
Raising their generics game
What’s APAC’s Recipe of Success in Clinical Trials Market?
Veeda Clinical Research Acquires European CRO – Heads – Expanding Global Reach & Capabilities
Public perception about clinical trials has witnessed a drastic change
Maturity & Quality of India Clinical Trial Ecosystem Has Been Very Well Demonstrated
Indian firm Veeda Clinical Research has strategically expanded its capabilities and global footprint
GBR Interview Mr. Ajay Tandon for India Lifesciences Series
Enabling Global Health: India’s Rise in Biologics Accessibility
Dr. Sanjib Banerjee, COO, Biopharma Division, Veeda Clinical Research Limited, delves into the current Biopharma industry trends, initiatives, and strategic advancements of the newly launched Biopharma Division
Akston Biosciences Doses First Volunteers in Phase II/III Clinical Trial of Low Cost, Shelf Stable COVID-19 Vaccine
